Holly Keeley
Neurology with Special Qualifications in Child Neurology · Austin, TXNPI 1104320944
Payments from drug & device makers
Across 144 payments — averaging $22.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$648
- Upsher-smith Laboratories LLC$419
- SK Life Science, Inc.$344
- Neurelis, Inc.$219
- Aucta Pharmaceuticals, Inc.$204
- Jazz Pharmaceuticals Inc.$188
- plus $1K from 31 others
What the payments were for
- Food & beverage$3,268100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 29 | $648 |
| Upsher-smith Laboratories LLC | 14 | $419 |
| SK Life Science, Inc. | 14 | $344 |
| Neurelis, Inc. | 10 | $219 |
| Aucta Pharmaceuticals, Inc. | 14 | $204 |
| Jazz Pharmaceuticals Inc. | 7 | $188 |
| Otter Pharmaceuticals, LLC | 5 | $122 |
| Ipsen Biopharmaceuticals, Inc | 4 | $118 |
| Ironshore Pharmaceuticals Inc. | 4 | $87 |
| Nobelpharma America, LLC | 1 | $84 |
| Biogen | 3 | $80 |
| Piramal Critical Care | 4 | $72 |
| Vertical Pharmaceuticals, LLC | 4 | $67 |
| Kyowa Kirin, Inc. | 3 | $66 |
| CSL Behring | 2 | $64 |
| Acadia Pharmaceuticals Inc | 2 | $54 |
| Collegium Pharmaceutical, Inc. | 2 | $33 |
| Neos Therapeutics, LP | 2 | $32 |
| Azurity Pharmaceuticals, Inc. | 1 | $28 |
| Corium, LLC | 2 | $26 |
| Aquestive Therapeutics, Inc. | 1 | $25 |
| Neurocrine Biosciences, Inc. | 1 | $24 |
| Pyros Pharmaceuticals, Inc. | 1 | $22 |
| AbbVie | 1 | $21 |
| Noven Therapeutics, LLC | 1 | $21 |
| Avion Pharmaceuticals | 1 | $21 |
| Pharming Healthcare, Inc. | 1 | $20 |
| Tris Pharma Inc | 1 | $19 |
| Catalyst Pharmaceuticals, Inc. | 1 | $19 |
| Harmony Biosciences LLC | 1 | $19 |
| Sanofi | 1 | $18 |
| Supernus Pharmaceuticals, Inc. | 1 | $18 |
| Biocodex, Inc. | 1 | $17 |
| Sarepta Therapeutics, Inc. | 1 | $15 |
| Genentech USA, Inc. | 1 | $13 |
| Livanova USA, Inc. | 1 | $12 |
| Metacel Pharmaceuticals LLC | 1 | $10 |
How this compares
$3,268 in reported general payments places this provider in the 60th percentile of 193 neurology with special qualifications in child neurology providers in Texas.
See all neurology with special qualifications in child neurology providers in Texas →
Other neurology with special qualifications in child neurology in Austin
- Dave ClarkeAustin$125K
- Samantha IrwinAustin$75K
- Shelly ReardonAustin$17K
- Huda ZoghbiHouston$8.3M
- Roy EltermanDallas$5.9M
- Diana CastroDenton$2.8M
- Jerry TomasovicSan Antonio$1.5M
- Mary Kay KoenigHouston$1.3M
- Davut PehlivanHouston$1M
- Michael PerryFort Worth$939K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.